Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nicola Hanania (Houston, United States of America). From clinical trials to real-world data: New dimensions of patient benefits. International Congress 2015 – IgE-mediated asthma: New revelations and future insights

Member's Comments

Sanjeev Kumar Mehta - 02.04.2016 16:47
Excellent content. Key slides not displayed

Related content which might interest you: Translating trials to clinical practice: results ²more real than real life itself²¹ Source: Annual Congress 2007 - Smoking cessation Year: 2007 Patient perspective of participation in COVID-19 clinical trials Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases Year: 2021 New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014 Pirfenidone: an update on clinical trial data and insights from everyday practice Source: Eur Respir Rev 2014; 23: 111-117 Year: 2014 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 How can real-world data be used to improve outcomes? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Large trials, new knowledge: the changing face of COPD management Source: Eur Respir J 2015; 45: 1692-1703 Year: 2015 Asthma quality of life in clinical trials - can we combine data from different countries? Source: Eur Respir J 2001; 18: Suppl. 33, 4s Year: 2001 Patients’ experience with and knowledge on clinical trials. Source: Virtual Congress 2020 – Evaluation of knowledge transfer into clinical practice Year: 2020 The way forward: how to link real-life situations and clinical trial results Source: Annual Congress 2013 - Lunchtime Session "Tiotropium soft mist inhaler and mortality in COPD: results of the TIOSPIR clinical trial" Year: 2013 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough Source: Eur Respir J 2015; 46: 607-614 Year: 2015 Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 A new model for clinical trials to address the COVID-19 emergency Source: Breathe, 16 (2) 200220; 10.1183/20734735.0220-2020 Year: 2020 Letting the right one in: evaluating the generalisability of clinical trials Source: Eur Respir J, 52 (6) 1802218; 10.1183/13993003.02218-2018 Year: 2018 New uses of data: from big data to artificial intelligence and clinical decision tools  in children with respiratory diseases Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001